Therapy Areas: AIDS & HIV
14 November 2019 - - A newly published study demonstrates clinical evidence for the effectiveness of a first-of-its-kind, FDA-cleared assay for the detection of the sexually transmitted bacterium ...
8 October 2019 - United States-based Johnson & Johnson is planning to invest more than USD500m in the next four years to help end the epidemics of HIV and tuberculosis, it was reported yesterday.T...
7 October 2019 - - The US Food and Drug Administration approved a pre-exposure prophylaxis indication for Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF), US-based Gilead...
7 October 2019 - The US Food and Drug Administration (FDA) has granted approval to United States-based Gilead Sciences for HIV pre-exposure prophylaxis indication of Descovy (emtricitabine 200mg and t...
4 October 2019 - The US Food and Drug Administration (FDA) said on Thursday that it has granted approval to Gilead Sciences Inc (NASDAQ:GILD) for Descovy (emtricitabine 200 mg and tenofovir alafenamid...
2 October 2019 - South Korea-based Celltrion is introducing its HIV drug Temixys in the United States, it was reported yesterday.The United States Food and Drug Administration (FDA) approved the produ...
Related Headlines